The Combination of Fludarabine, Cyclophosphamide, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphoma
- 1 June 2005
- journal article
- research article
- Published by Elsevier BV in Clinical Lymphoma
- Vol. 6 (1), 26-30
- https://doi.org/10.3816/clm.2005.n.023
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2001
- Salvage Chemotherapy Using a Combination of Fludarabine and Cyclophosphamide for Refractory or Relapsing Indolent and Aggressive Non-Hodgkin's LymphomasLeukemia & Lymphoma, 1999
- Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemiaLeukemia, 1997
- Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.Proceedings of the National Academy of Sciences of the United States of America, 1996
- In Vivo Administration of Recombinant Macrophage Colony-Stimulating Factor Induces Macrophage-Mediated Antibody-Dependent Cytotoxicity of Tumor CellsJournal of Immunotherapy, 1992
- Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1990
- Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primatesBlood, 1990
- Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.The Journal of Experimental Medicine, 1989
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working groupAmerican Journal of Hematology, 1988
- Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating FactorScience, 1986